<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu"><title>daily digest</title><link>http://eatg.tttp.eu</link><description></description><items><rdf:Seq><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Treatment/Intelence-etravirine-label-revised-to-include-new-drug-drug-interaction-information"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Time-for-drug-giants-to-jump-into-the-patent-pool"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Access-to-treatment/People-living-with-HIV-AIDS-India-must-not-sacrifice-us-in-trade-agreement-with-Europe"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/HIV-STIs/Nucleic-acid-amplification-testing-detects-extragenital-STIs-missed-by-cultures-in-young-HIV-infected-patients"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Visa-refusal-shines-spotlight-on-China-s-HIV-travel-ban"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Hepatitis/Poor-response-to-hepatitis-B-vaccine-predicts-HIV-disease-progression"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Zimbabwe-Donor-HIV-AIDS-funding-declines"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Prevention/Scientists-learning-how-monkeys-fend-off-monkey-AIDS"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Former-President-Clinton-Bill-Gates-encourage-U.S.-global-health-investment-at-Senate-Foreign-Relations-Committee-hearing"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Indian-civil-society-raises-concerns-over-US-industry-sponsored-IP-summits"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/EU-Policy/European-Parliament-votes-to-rein-in-anti-counterfeiting-treaty"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/World-Policy/IAS-leaders-promote-access-to-evidence-based-HIV-prevention-and-treatment-for-people-who-use-drugs"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/WHO-releases-new-malaria-guidelines-for-treatment-and-procurement-of-medicines"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Prevention/Do-needle-exchange-programs-really-work"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Call-for-urgent-action-to-improve-coverage-of-HIV-services-for-injecting-drug-users"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Treatment/Replication-capacity-an-additional-measure-of-HIV-disease-progression"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Treatment/Invasive-non-typhoid-salmonellae-becoming-important-pathogen-in-HIV-patients"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/Tuberculosis-reinfection-rates-are-higher-in-HIV-infected-patients"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/MSM/Rates-of-new-HIV-diagnoses-amongst-US-gay-men-44-times-greater-than-those-in-other-populations"/><rdf:li rdf:resource="http://eatg.tttp.eu/Global-HIV-News/Treatment/HIV-positive-boys-have-reduced-bone-density"/></rdf:Seq></items></channel><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Treatment/Intelence-etravirine-label-revised-to-include-new-drug-drug-interaction-information"><title>Intelence (etravirine) label revised to include new drug-drug interaction information</title><link>http://eatg.tttp.eu/Global-HIV-News/Treatment/Intelence-etravirine-label-revised-to-include-new-drug-drug-interaction-information</link><description>FDA recently updated Intelence (etravirine) label to include drug-drug interaction information between etravirine and fluconazole, voriconazole, lopinavir/ritonavir tablets and clopidogrel. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Time-for-drug-giants-to-jump-into-the-patent-pool"><title>Time for drug giants to jump into the patent pool?</title><link>http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Time-for-drug-giants-to-jump-into-the-patent-pool</link><description>A patent pool is a virtual concept, involving patent-holding drug companies allowing anybody to make cheap copies of their drugs or - importantly - combine the drugs of several different big R&amp;D companies in a single pill for adults or children.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Access-to-treatment/People-living-with-HIV-AIDS-India-must-not-sacrifice-us-in-trade-agreement-with-Europe"><title>People living with HIV/AIDS: India must not sacrifice us in trade agreement with Europe</title><link>http://eatg.tttp.eu/Global-HIV-News/Access-to-treatment/People-living-with-HIV-AIDS-India-must-not-sacrifice-us-in-trade-agreement-with-Europe</link><description>As the final round of closed-door negotiations for a Free Trade Agreement (FTA) between India and the European Union (EU) is about to start this month, people living with HIV/AIDS are protesting to ensure Indian negotiators do not give in to pressure to accept terms that will seriously hamper access to medicines for millions of people living in the developing world.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/HIV-STIs/Nucleic-acid-amplification-testing-detects-extragenital-STIs-missed-by-cultures-in-young-HIV-infected-patients"><title>Nucleic аcid аmplification testing detects extragenital STIs missed by cultures in young HIV-infected patients</title><link>http://eatg.tttp.eu/Global-HIV-News/HIV-STIs/Nucleic-acid-amplification-testing-detects-extragenital-STIs-missed-by-cultures-in-young-HIV-infected-patients</link><description>Nucleic acid amplification testing (NAAT) for gonorrhea and chlamydia at extragenital sites might detect more positive cases than does the use of cultures at these sites, according to a new study.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Visa-refusal-shines-spotlight-on-China-s-HIV-travel-ban"><title>Visa refusal shines spotlight on China's HIV travel ban </title><link>http://eatg.tttp.eu/Global-HIV-News/World-Policy/Visa-refusal-shines-spotlight-on-China-s-HIV-travel-ban</link><description>A spotlight has fallen on China’s continued entry ban for HIV-positive foreigners after HIV-positive Australian novelist Robert Dessaix was refused entry to the country. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Hepatitis/Poor-response-to-hepatitis-B-vaccine-predicts-HIV-disease-progression"><title>Poor response to hepatitis B vaccine predicts HIV disease progression</title><link>http://eatg.tttp.eu/Global-HIV-News/Hepatitis/Poor-response-to-hepatitis-B-vaccine-predicts-HIV-disease-progression</link><description>Individuals who respond well to hepatitis B vaccination have a lower risk of experiencing HIV disease progression, while those who respond poorly are more likely to develop AIDS or die - independent of CD4 count. The researchers suggested that ability to respond to the vaccine reflects many aspects of immune function that may contribute to slower disease progression. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Zimbabwe-Donor-HIV-AIDS-funding-declines"><title>Zimbabwe: Donor HIV/AIDS funding declines</title><link>http://eatg.tttp.eu/Global-HIV-News/World-Policy/Zimbabwe-Donor-HIV-AIDS-funding-declines</link><description>HIV and AIDS funding from the donor community has decreased by more than 50 percent since 2006, the National AIDS Council has said.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Prevention/Scientists-learning-how-monkeys-fend-off-monkey-AIDS"><title>Scientists learning how monkeys fend off “monkey AIDS”</title><link>http://eatg.tttp.eu/Global-HIV-News/Prevention/Scientists-learning-how-monkeys-fend-off-monkey-AIDS</link><description>Bi­ol­o­gists say they have dis­cov­ered a key rea­son why mon­key im­mune sys­tems are usu­ally able to keep the mon­key ver­sion of the vi­rus be­hind AIDS in check.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Former-President-Clinton-Bill-Gates-encourage-U.S.-global-health-investment-at-Senate-Foreign-Relations-Committee-hearing"><title>Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing</title><link>http://eatg.tttp.eu/Global-HIV-News/World-Policy/Former-President-Clinton-Bill-Gates-encourage-U.S.-global-health-investment-at-Senate-Foreign-Relations-Committee-hearing</link><description>"U.S. investments in fighting HIV/AIDS, malaria and other diseases in underdeveloped nations save lives and play a vital role in improving America's image abroad."</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Indian-civil-society-raises-concerns-over-US-industry-sponsored-IP-summits"><title>Indian civil society raises concerns over US industry-sponsored IP summits </title><link>http://eatg.tttp.eu/Global-HIV-News/World-Policy/Indian-civil-society-raises-concerns-over-US-industry-sponsored-IP-summits</link><description>Public interest groups in India are raising questions over annual summits involving Indian judges and policymakers that are being funded by major western industry groups, in particular pharmaceutical companies. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/EU-Policy/European-Parliament-votes-to-rein-in-anti-counterfeiting-treaty"><title>European Parliament votes to rein in anti-counterfeiting treaty </title><link>http://eatg.tttp.eu/Global-HIV-News/EU-Policy/European-Parliament-votes-to-rein-in-anti-counterfeiting-treaty</link><description>The European Parliament voted overwhelmingly in favour of a demand to be kept fully informed about the secretive Anti-Counterfeiting Trade Agreement under negotiation by the European Commission and about a dozen countries outside Europe. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/World-Policy/IAS-leaders-promote-access-to-evidence-based-HIV-prevention-and-treatment-for-people-who-use-drugs"><title>IAS leaders promote access to evidence-based HIV prevention and treatment for people who use drugs </title><link>http://eatg.tttp.eu/Global-HIV-News/World-Policy/IAS-leaders-promote-access-to-evidence-based-HIV-prevention-and-treatment-for-people-who-use-drugs</link><description>Speaking at a press briefing during the fifty-third session of the Commission on Narcotic Drugs, organizers of the XVIII International AIDS Conference highlighted the important role the conference will play in advancing efforts to increase access to programmes proven to lower HIV infection rates and improve access to HIV treatment among people who use drugs.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/WHO-releases-new-malaria-guidelines-for-treatment-and-procurement-of-medicines"><title>WHO releases new malaria guidelines for treatment and procurement of medicines</title><link>http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/WHO-releases-new-malaria-guidelines-for-treatment-and-procurement-of-medicines</link><description>The World Health Organization (WHO) is releasing new guidelines for the treatment of malaria, and the first ever guidance on procuring safe and efficacious anti-malarial medicines. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Prevention/Do-needle-exchange-programs-really-work"><title>Do needle-exchange programs really work?</title><link>http://eatg.tttp.eu/Global-HIV-News/Prevention/Do-needle-exchange-programs-really-work</link><description>Needle-exchange programs designed to cut injection drug users' risk of HIV, the virus that causes AIDS, and other infections do seem to reduce needle sharing, but there is only limited evidence that they lower disease transmission, a new research review concludes.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/World-Policy/Call-for-urgent-action-to-improve-coverage-of-HIV-services-for-injecting-drug-users"><title>Call for urgent action to improve coverage of HIV services for injecting drug users</title><link>http://eatg.tttp.eu/Global-HIV-News/World-Policy/Call-for-urgent-action-to-improve-coverage-of-HIV-services-for-injecting-drug-users</link><description>A review carried out by the 2009 Reference Group to the UN on HIV and Injecting Drug Use for the first time quantifies the scale of coverage of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide. </description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Treatment/Replication-capacity-an-additional-measure-of-HIV-disease-progression"><title>Replication capacity: an additional measure of HIV disease progression?</title><link>http://eatg.tttp.eu/Global-HIV-News/Treatment/Replication-capacity-an-additional-measure-of-HIV-disease-progression</link><description>HIV’s replication capacity (RC), a measurement of the virus’s fitness, may be useful for people living with HIV and their health care providers in figuring out how quickly HIV disease will progress.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Treatment/Invasive-non-typhoid-salmonellae-becoming-important-pathogen-in-HIV-patients"><title>Invasive non-typhoid salmonellae becoming important pathogen in HIV patients</title><link>http://eatg.tttp.eu/Global-HIV-News/Treatment/Invasive-non-typhoid-salmonellae-becoming-important-pathogen-in-HIV-patients</link><description>Non-typhoid salmonellae (NTS) - a source of self-limited illness in healthy individuals -- produce severe recurrent disease in African patients with HIV infection, and now researchers have found that the African infections are intracellular and not simply intravascular.</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/Tuberculosis-reinfection-rates-are-higher-in-HIV-infected-patients"><title>Tuberculosis reinfection rates are higher in HIV-infected patients</title><link>http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/Tuberculosis-reinfection-rates-are-higher-in-HIV-infected-patients</link><description>"Tuberculosis recurrence rates, likely due to reinfection, were much higher than incidence rates. The findings suggest heterogeneity in susceptibility, implying that a vaccine could still provide useful protection in the population and strengthening the case for secondary preventive therapy."</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/MSM/Rates-of-new-HIV-diagnoses-amongst-US-gay-men-44-times-greater-than-those-in-other-populations"><title>Rates of new HIV diagnoses amongst US gay men 44 times greater than those in other populations </title><link>http://eatg.tttp.eu/Global-HIV-News/MSM/Rates-of-new-HIV-diagnoses-amongst-US-gay-men-44-times-greater-than-those-in-other-populations</link><description>HIV has a hugely disproportionate impact on gay and other men who have sex with men in the US, according to new figures released by the US Centers for Disease Control and Surveillance (CDC).</description></item><item xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:about="http://eatg.tttp.eu/Global-HIV-News/Treatment/HIV-positive-boys-have-reduced-bone-density"><title>HIV-positive boys have reduced bone density </title><link>http://eatg.tttp.eu/Global-HIV-News/Treatment/HIV-positive-boys-have-reduced-bone-density</link><description>HIV-positive pubescent boys have significantly lower bone mineral content and density than their HIV-negative peers, US investigators report in the online edition of AIDS. The researchers also found that treatment with Kaletra was associated with reduced bone mineral content and density.</description></item></rdf:RDF>
